12-65051408-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_007191.5(WIF1):c.1081C>A(p.Pro361Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00166 in 1,613,846 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0091 ( 14 hom., cov: 32)
Exomes 𝑓: 0.00089 ( 7 hom. )
Consequence
WIF1
NM_007191.5 missense
NM_007191.5 missense
Scores
2
4
12
Clinical Significance
Conservation
PhyloP100: 5.40
Genes affected
WIF1 (HGNC:18081): (WNT inhibitory factor 1) The protein encoded by this gene functions to inhibit WNT proteins, which are extracellular signaling molecules that play a role in embryonic development. This protein contains a WNT inhibitory factor (WIF) domain and five epidermal growth factor (EGF)-like domains, and is thought to be involved in mesoderm segmentation. This gene functions as a tumor suppressor gene, and has been found to be epigenetically silenced in various cancers. [provided by RefSeq, Jun 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.009321958).
BP6
Variant 12-65051408-G-T is Benign according to our data. Variant chr12-65051408-G-T is described in ClinVar as [Benign]. Clinvar id is 710452.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00905 (1379/152348) while in subpopulation AFR AF= 0.0306 (1272/41568). AF 95% confidence interval is 0.0292. There are 14 homozygotes in gnomad4. There are 656 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 14 gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WIF1 | ENST00000286574.9 | c.1081C>A | p.Pro361Thr | missense_variant | 10/10 | 1 | NM_007191.5 | ENSP00000286574.4 | ||
WIF1 | ENST00000543094.1 | c.328C>A | p.Pro110Thr | missense_variant | 5/5 | 5 | ENSP00000439024.1 | |||
ENSG00000198671 | ENST00000360528.3 | n.1036-2694G>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00899 AC: 1369AN: 152230Hom.: 14 Cov.: 32
GnomAD3 genomes
AF:
AC:
1369
AN:
152230
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00246 AC: 616AN: 249982Hom.: 4 AF XY: 0.00177 AC XY: 239AN XY: 135248
GnomAD3 exomes
AF:
AC:
616
AN:
249982
Hom.:
AF XY:
AC XY:
239
AN XY:
135248
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000892 AC: 1304AN: 1461498Hom.: 7 Cov.: 30 AF XY: 0.000740 AC XY: 538AN XY: 727048
GnomAD4 exome
AF:
AC:
1304
AN:
1461498
Hom.:
Cov.:
30
AF XY:
AC XY:
538
AN XY:
727048
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00905 AC: 1379AN: 152348Hom.: 14 Cov.: 32 AF XY: 0.00881 AC XY: 656AN XY: 74494
GnomAD4 genome
AF:
AC:
1379
AN:
152348
Hom.:
Cov.:
32
AF XY:
AC XY:
656
AN XY:
74494
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
0
ESP6500AA
AF:
AC:
153
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
362
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 18, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Pathogenic
D;D
Sift4G
Pathogenic
D;D
Polyphen
B;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at